Following Stockholder Approval, BIO-key Announces 1-for-10 Reverse Stock Split
Rhea-AI Summary
BIO-key (Nasdaq: BKYI) announced a 1-for-10 reverse stock split effective with the opening of trading on April 30, 2026. The company had ~10.9 million shares outstanding as of April 28, 2026; post-split it will have ~1.1 million shares outstanding.
The Board approved the ratio after stockholder approval to assist BIO-key in regaining compliance with the Nasdaq minimum bid price requirement. According to the company, management is executing growth goals that include achieving profitability in the first half of 2026.
Positive
- Reverse split ratio set at 1-for-10
- Shares outstanding reduced from ~10.9M to ~1.1M
- Effective date scheduled for April 30, 2026
- Company objective to regain Nasdaq minimum bid price compliance
Negative
- Pre-split noncompliance with minimum bid price requirement implied
- Outstanding shares cut by ~90%, which may affect trading liquidity
- Outcome uncertain — split assists compliance but does not guarantee continued listing
News Market Reaction – BKYI
In the Apr 28 session, BKYI declined 14.32%, reflecting a significant negative market reaction. Argus tracked a trough of -14.8% from its starting point during tracking. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 22 | Nasdaq non-compliance | Negative | -5.5% | Notice of non-compliance for delayed Form 10-K filing from Nasdaq. |
| Apr 16 | Outlook update | Positive | +6.3% | Guidance for ~50% 1H 2026 revenue growth and expected profitability. |
| Mar 31 | Earnings results | Negative | -11.3% | 2025 revenue decline and wider net loss despite stronger cash position. |
| Mar 25 | Investor call notice | Neutral | +6.3% | Announcement of upcoming year-end investor call and webcast details. |
| Mar 12 | Strategic partnership | Positive | +4.3% | Partnership with TD SYNNEX Public Sector to expand IAM solutions reach. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
BKYI has recently seen aligned price moves on both positive growth updates and compliance-related setbacks, with occasional rallies on neutral event announcements.
Over the last few months, BKYI news has mixed operational progress with listing and filing challenges. A Mar 12, 2026 partnership with TD SYNNEX Public Sector lifted shares, as did a Mar 25, 2026 investor call announcement. However, 2025 results on Mar 31, 2026 and a Nasdaq non-compliance notice on Apr 22, 2026 coincided with declines. A 50% first-half 2026 revenue growth outlook on Apr 16, 2026 drew a positive reaction. Today’s reverse split follows stockholder approvals and earlier non-compliance notices.
Key Terms
reverse stock split financial
minimum bid price requirement regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
HOLMDEL, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today announced that it has approved a 1-for-10 reverse stock split that will become effective with the commencement of trading on April 30, 2026.
BIO-key stockholders approved a proposal last week to allow the Board to proceed with a reverse split to assist the Company in its effort to regain compliance with the minimum bid price requirement.
BIO-key had approximately 10.9 million shares of common stock issued and outstanding as of April 28, 2026. After giving effect to the 1-for-10 reverse stock split, BIO-key will have approximately 1.1 million shares of common stock issued and outstanding.
BIO-key CEO Michael DePasquale commented, “The Board’s decision to set the ratio at 1-for-10 was intended to position our common stock for minimum bid price compliance as we execute on our growth goals, including profitability in the first half of 2026.”
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate,” “project,” “intends,” “expects,” “anticipates,” “believes” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management’s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the “safe-harbor” provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology and identity access management industries; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to migrate Swivel Secure customers to BIO-key and Portal Guard offerings; our ability to execute definitive agreements with Fiber Food Systems and/or its customers to utilize our access management solutions; our ability to integrate our solutions into any of Fiber Food System’s offerings; fluctuations in foreign currency exchange rates; the duration and extent of continued hostilities in Ukraine and its impact on our European customers; the impact of tariffs and other trade barriers which may make it more costly for us to import inventory from China and Hong Kong and certain product components from South Korea; delays in the development of products, the commercial, reputational and regulatory risks to our business that may arise as a consequence of non-compliance with Securities and Exchange Commission (“SEC”) and Nasdaq periodic reporting requirements; our temporary loss of the use of a Registration Statement on Form S-3 to register securities in the future; any disruption to our business that may occur on a longer-term basis should we be unable to continue to maintain effective internal controls over financial reporting, and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024 and other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.
| Engage with BIO-key: | |
| Facebook – Corporate: | https://www.facebook.com/BIOkeyInternational/ |
| LinkedIn – Corporate: | https://www.linkedin.com/company/bio-key-international |
| X – Corporate: | @BIOkeyIntl |
| X – Investors: | @BIO_keyIR |
| StockTwits: | BIO_keyIR |
Investor Contacts:
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com or 212-924-9800
